0001562180-23-000495.txt : 20230118
0001562180-23-000495.hdr.sgml : 20230118
20230118200400
ACCESSION NUMBER: 0001562180-23-000495
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230113
FILED AS OF DATE: 20230118
DATE AS OF CHANGE: 20230118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COHEN RAYMOND W
CENTRAL INDEX KEY: 0001258288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 23535681
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2023-01-13
false
0001603756
Axonics, Inc.
AXNX
0001258288
COHEN RAYMOND W
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
true
true
false
false
Chief Executive Officer
Common Stock
2023-01-13
4
S
false
18684.00
65.5409
D
130951.00
D
Common Stock
2023-01-13
4
S
false
22052.00
66.2722
D
108899.00
D
This transaction was executed in multiple trades at prices ranging from $65.00 to $65.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $66.00 to $66.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Dan Dearen, as Attorney-in-Fact for Raymond W. Cohen
2023-01-18